Ceprotin Purple Book BLA 125234

BLA number
125234
Proprietary names
Ceprotin
Proper names
Protein C Concentrate (Human)
Applicant
Takeda Pharmaceuticals U.S.A., Inc.
Center
CBER
First observed release
2020-08-01
Latest observed release
2026-06-01
Newest archive release
2026-06-01
FDA patent list
No patents listed in the captured FDA patent list; source updated 2025-06-11
Coverage
Present in newest release

Latest Known Product Presentations#

Product, Proprietary name, Proper name table
ProductProprietary nameProper nameLicense typeStrengthDosage formRoutePresentationMarketingLicensureApprovalPatent list provided
001CeprotinProtein C Concentrate (Human)351(a)500IUFor InjectionIntravenousSingle-Dose VialRxLicensed2007-03-30
002CeprotinProtein C Concentrate (Human)351(a)1000IUFor InjectionIntravenousSingle-Dose VialRxLicensed2007-03-30

Published Patent List#

No patents for this BLA were listed in the FDA Purple Book patent list captured from the source updated 2025-06-11.

Official Monthly Change Events#

Release, Event, Product table
ReleaseEventProductNameLicense typeStatusApplicant
2023-05-01U001Ceprotin351(a)RxTakeda Pharmaceuticals U.S.A., Inc.
2023-05-01U002Ceprotin351(a)RxTakeda Pharmaceuticals U.S.A., Inc.
2021-09-01U001Ceprotin351(a)RxBaxalta US Inc.
2021-09-01U002Ceprotin351(a)RxBaxalta US Inc.
2021-05-01U001Ceprotin351(a)RxBaxalta US Inc.
2021-05-01U002Ceprotin351(a)RxBaxalta US Inc.
2020-08-01R001Ceprotin351(a)RxBaxalta US Inc.
2020-08-01R002Ceprotin351(a)RxBaxalta US Inc.

Observed Product State History#

Release, Product, Name table
ReleaseProductNameLicense typeMarketingLicensureApproval
2020-08-01001Ceprotin351(a)RxLicensed2007-03-30
2020-08-01002Ceprotin351(a)RxLicensed2007-03-30